| Primary |
| Glomerulonephritis Membranous |
14.5% |
| Cerebrovascular Accident |
7.5% |
| Hypertension |
7.5% |
| Transient Ischaemic Attack |
7.0% |
| Cardiomyopathy |
6.5% |
| Kawasaki's Disease |
5.9% |
| Cardiac Stress Test |
5.4% |
| Myocardial Ischaemia |
5.4% |
| Cardiovascular Event Prophylaxis |
4.8% |
| Essential Thrombocythaemia |
4.8% |
| Thrombosis Prophylaxis |
4.8% |
| Cerebrovascular Accident Prophylaxis |
3.8% |
| Diabetes Mellitus |
3.2% |
| Maternal Exposure During Pregnancy |
3.2% |
| Prophylaxis |
3.2% |
| Atrial Fibrillation |
2.7% |
| Nephritis |
2.7% |
| Nephrotic Syndrome |
2.7% |
| Anticoagulant Therapy |
2.2% |
| Cerebral Ischaemia |
2.2% |
|
| Pharmaceutical Product Complaint |
10.8% |
| Vomiting |
9.2% |
| Gastrointestinal Haemorrhage |
7.7% |
| Diverticulitis Intestinal Haemorrhagic |
6.2% |
| Cerebral Infarction |
4.6% |
| Duodenal Ulcer Haemorrhage |
4.6% |
| Gastric Ulcer Haemorrhage |
4.6% |
| Haemorrhage |
4.6% |
| Injection Site Pain |
4.6% |
| Liver Disorder |
4.6% |
| Muscle Haemorrhage |
4.6% |
| Myalgia |
4.6% |
| Myocardial Infarction |
4.6% |
| Neoplasm Malignant |
4.6% |
| Toxic Epidermal Necrolysis |
4.6% |
| Cardiac Disorder |
3.1% |
| Cerebellar Haemorrhage |
3.1% |
| Diarrhoea |
3.1% |
| Fatigue |
3.1% |
| Gastrointestinal Carcinoma |
3.1% |
|
| Secondary |
| Glomerulonephritis Membranous |
11.9% |
| Hypertension |
11.9% |
| Diffuse Large B-cell Lymphoma |
9.3% |
| Product Used For Unknown Indication |
9.3% |
| Transient Ischaemic Attack |
6.2% |
| Essential Thrombocythaemia |
5.3% |
| Prophylaxis |
5.3% |
| Hypercholesterolaemia |
4.9% |
| Cardiovascular Event Prophylaxis |
4.4% |
| Systemic Lupus Erythematosus |
4.0% |
| Amaurosis Fugax |
3.5% |
| Angina Pectoris |
3.5% |
| Influenza |
3.5% |
| Kawasaki's Disease |
3.1% |
| Overdose |
2.7% |
| Suicide Attempt |
2.7% |
| Drug Use For Unknown Indication |
2.2% |
| Gastritis |
2.2% |
| Glomerulonephritis Chronic |
2.2% |
| Iron Deficiency Anaemia |
1.8% |
|
| Thrombocytopenia |
12.5% |
| Gastrointestinal Haemorrhage |
7.5% |
| No Adverse Event |
7.5% |
| Toxic Epidermal Necrolysis |
7.5% |
| Atrioventricular Block First Degree |
5.0% |
| Back Pain |
5.0% |
| Dysarthria |
5.0% |
| Fall |
5.0% |
| Feeling Abnormal |
5.0% |
| Menorrhagia |
5.0% |
| Pyrexia |
5.0% |
| Subarachnoid Haemorrhage |
5.0% |
| Transient Ischaemic Attack |
5.0% |
| Urinary Retention |
5.0% |
| Abdominal Discomfort |
2.5% |
| Abortion Induced |
2.5% |
| Agranulocytosis |
2.5% |
| Angina Pectoris |
2.5% |
| Atrial Fibrillation |
2.5% |
| Autoimmune Hepatitis |
2.5% |
|
| Concomitant |
| Hypertension |
17.1% |
| Product Used For Unknown Indication |
16.0% |
| Lupus Nephritis |
8.6% |
| Rheumatoid Arthritis |
6.0% |
| Drug Use For Unknown Indication |
5.3% |
| Angina Pectoris |
5.0% |
| Prophylaxis |
4.5% |
| Diabetes Mellitus |
3.8% |
| Hyperlipidaemia |
3.4% |
| Gastric Ulcer |
3.2% |
| Asthma |
3.0% |
| Hypercholesterolaemia |
3.0% |
| Osteoporosis |
3.0% |
| Cardiac Failure |
2.9% |
| Hyperuricaemia |
2.7% |
| Pain |
2.7% |
| Pulmonary Arterial Hypertension |
2.7% |
| Depression |
2.6% |
| Nephrogenic Anaemia |
2.3% |
| Insomnia |
2.2% |
|
| White Blood Cell Count Decreased |
10.6% |
| Renal Impairment |
9.9% |
| Cerebrovascular Accident |
6.8% |
| Death |
6.8% |
| Pneumonia |
6.2% |
| Vomiting |
6.2% |
| Platelet Count Decreased |
5.6% |
| Thrombocytopenia |
5.6% |
| Osteoporosis |
5.0% |
| Nephrotic Syndrome |
4.3% |
| Sepsis |
4.3% |
| Urinary Tract Infection |
3.7% |
| Amnesia |
3.1% |
| Feeling Abnormal |
3.1% |
| Irritability |
3.1% |
| Lung Neoplasm Malignant |
3.1% |
| Renal Disorder |
3.1% |
| Renal Failure |
3.1% |
| Stomatitis |
3.1% |
| Transient Ischaemic Attack |
3.1% |
|
